{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T21:38:29Z","timestamp":1779399509290,"version":"3.53.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.bbmt.2017.02.003","type":"journal-article","created":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T05:21:18Z","timestamp":1486617678000},"page":"782-789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cytogenetic Evolution in Myeloid Neoplasms at Relapse after Allogeneic Hematopoietic Cell Transplantation: Association with Previous Chemotherapy and Effect on Survival"],"prefix":"10.1016","volume":"23","author":[{"given":"Natalie","family":"Ertz-Archambault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Kosiorek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Slack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa L.","family":"Lonzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia T.","family":"Greipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandita","family":"Khera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Kelemen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2017.02.003_bib0010","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature10738","article-title":"Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing","volume":"481","author":"Ding","year":"2012","journal-title":"Nature"},{"issue":"1 suppl","key":"10.1016\/j.bbmt.2017.02.003_bib0015","doi-asserted-by":"crossref","first-page":"S138","DOI":"10.1016\/j.bbmt.2009.10.023","article-title":"Relapse after allogeneic hematopoietic cell therapy","volume":"16","author":"van den Brink","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.02.003_bib0020","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.bbmt.2010.06.007","article-title":"Comparison of cytogenetic clonal evolution patterns following allogeneic hematopoietic transplantation versus conventional treatment in patients at relapse of AML","volume":"16","author":"Bacher","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.02.003_bib0025","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1038\/sj.leu.2402654","article-title":"Karyotype instability between diagnosis and relapse in 117 patients with acute myeloid leukemia: implications for resistance against therapy","volume":"16","author":"Kern","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2017.02.003_bib0030","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cancergencyto.2010.01.005","article-title":"Cytogenetic studies in acute leukemia patients relapsing after allogeneic stem cell transplantation","volume":"198","author":"Schmidt-Hieber","year":"2010","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.bbmt.2017.02.003_bib0035","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1182\/blood-2012-03-418202","article-title":"A disease risk index for patients undergoing allogeneic stem cell transplantation","volume":"120","author":"Armand","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.02.003_bib0040","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","year":"2008"},{"key":"10.1016\/j.bbmt.2017.02.003_bib0045","series-title":"An international system for human cytogenetic nomenclature: recommendations of the International Standing Committee on Human Cytogenetic Nomenclature","year":"2009"},{"key":"10.1016\/j.bbmt.2017.02.003_bib0050","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/sj.bmt.1705560","article-title":"Cytogenetic evolution patterns in CML post-SCT","volume":"39","author":"Karrman","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.02.003_bib0055","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1038\/sj.leu.2402713","volume":"16","author":"Mauritzson","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2017.02.003_bib0060","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/sj.leu.2402550","article-title":"Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation","volume":"16","author":"Perez-Simon","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2017.02.003_bib0065","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1002\/cncr.26539","article-title":"Prognostic impact of discordant results from cytogenetics and flow cytometry in patients with acute myeloid leukemia undergoing hematopoietic cell transplantation","volume":"118","author":"Fang","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2017.02.003_bib0070","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.02.003_bib0075","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","article-title":"Clinical and biological implications of driver mutations in myelodysplastic syndromes","volume":"122","author":"Papaemmanuil","year":"2013","journal-title":"Blood"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879117302719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879117302719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:57:43Z","timestamp":1761058663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879117302719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S1083879117302719"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2017.02.003","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytogenetic Evolution in Myeloid Neoplasms at Relapse after Allogeneic Hematopoietic Cell Transplantation: Association with Previous Chemotherapy and Effect on Survival","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2017.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}